A carregar...
Lack of Reduction in Buprenorphine Injection After Introduction of Co-Formulated Buprenorphine/Naloxone to the Malaysian Market
BACKGROUND: Diversion of buprenorphine (BPN) has been described in settings where it is legally prescribed and has resulted in increasing concern. To address this concern, co-formulation of buprenorphine/naloxone (BPN/NLX) replaced buprenorphine alone in Malaysia in December 2006. METHODS: To assess...
Na minha lista:
| Main Authors: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2009
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2791788/ https://ncbi.nlm.nih.gov/pubmed/19212931 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/00952990802585406 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|